Keros Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Keros Therapeutics's balance sheet done over the years? Its assets were worth $370,025,000 last year, which is more than in the previous period. 10% of Keros Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $37,812,000, which means an increase by 29% compared compared to last year.

Debt to Assets

Keros Therapeutics, Inc. (NASDAQ:KROS): Debt to assets
2018 27412000 14.65M 53.46%
2019 10955000 5.50M 50.24%
2020 269443000 7.72M 2.87%
2021 255251000 12.07M 4.73%
2022 306781000 29.35M 9.57%
2023 370025000 37.81M 10.22%

KROS Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
331.14M279.04M230.04M265.87M7.02M23.25M
Short term investments
000000
Net receivables
1.09M841K18M216K922K0
Inventory
0-841K3.05M1.47M759K0
Other current assets
15.05M6.71M340K160K226K84K
Total current assets
347.29M285.76M251.44M267.72M8.92M25.53M
Non-current assets:
Property, Plant and Equipment
19.46M17.56M2.40M1.60M1.91M1.38M
Goodwill
000000
Intangible assets
000000
Long term investments
1.21M1.32M1.32M115K115K0
Other non-current assets
2.05M2.11M82K00501K
Total non-current assets
22.73M21.01M3.81M1.71M2.02M1.88M
Total assets
370.02M306.78M255.25M269.44M10.95M27.41M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
007.13M4.39M1.91M10M
Short term debt
1.00M455K862K423K376K166K
Total current liabilities
24.37M16.54M11.84M7.18M4.48M11.46M
Non-current liabilities:
Long term debt
13.43M12.81M231K476K899K622K
Deferred tax
000000
Other non-current liabilities
00062K119K2.56M
Total non-current liabilities
13.43M12.81M231K538K1.01M3.18M
Total liabilities
37.81M29.35M12.07M7.72M5.50M14.65M
Data sourceData sourceData source